An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.
Researchers from Syracuse University (NY, USA) have developed a novel class of nanobiosensor that could detect, characterize and analyze protein–protein interactions in blood serum to assist in cancer detection.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Researchers at the Brigham Young University (London, UK) have developed a non-invasive, nanoPOTS method for monitoring cancer by measuring the proteins in circulating tumor cells from the blood.
Researchers at the CEU Cardenal Herrera University (Valencia, Spain) have discovered the three most efficient types of salivary biomarkers for the early detection of oral cancer.